BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9219021)

  • 1. Giving scientists their due. The Imanishi-Kari decision.
    Dresser R
    Hastings Cent Rep; 1997; 27(3):26-8. PubMed ID: 9219021
    [No Abstract]   [Full Text] [Related]  

  • 2. The federal research misconduct regulations as viewed from the research universities.
    Wright DE
    Centen Rev; 1994; 38(2):249-72. PubMed ID: 11656759
    [No Abstract]   [Full Text] [Related]  

  • 3. ORI finds Imanishi-Kari guilty of misconduct, proposes 10-year ban.
    Gavaghan H
    Nature; 1994 Dec; 372(6505):391. PubMed ID: 7984221
    [No Abstract]   [Full Text] [Related]  

  • 4. Imanishi-Kari still in limbo.
    Nature; 1994 Mar; 368(6466):1-2. PubMed ID: 8107875
    [No Abstract]   [Full Text] [Related]  

  • 5. Appeals board exonerates Baltimore, Imanishi-Kari.
    Marwick C
    JAMA; 1996 Jul 24-31; 276(4):266. PubMed ID: 8656524
    [No Abstract]   [Full Text] [Related]  

  • 6. Salem comes to the National Institutes of Health: notes from inside the crucible of scientific integrity.
    Needleman HL
    Pediatrics; 1992 Dec; 90(6):977-81. PubMed ID: 1331947
    [No Abstract]   [Full Text] [Related]  

  • 7. Imanishi-Kari case. Marathon hearing gets under way.
    Mervis J
    Science; 1995 Jun; 268(5217):1561. PubMed ID: 7777851
    [No Abstract]   [Full Text] [Related]  

  • 8. What to do about scientific misconduct.
    Nature; 1994 May; 369(6478):261-2. PubMed ID: 8183349
    [No Abstract]   [Full Text] [Related]  

  • 9. 'Misconduct' dispute raises fears of litigation.
    Dalton R
    Nature; 1997 Jan; 385(6612):105. PubMed ID: 8990102
    [No Abstract]   [Full Text] [Related]  

  • 10. Scientific misconduct. Back to the drawing board.
    Anderson C
    Nature; 1991 Mar; 350(6314):100. PubMed ID: 1848681
    [No Abstract]   [Full Text] [Related]  

  • 11. Imanishi-Kari case: ORI finds fraud.
    Stone R; Marshall E
    Science; 1994 Dec; 266(5190):1468-9. PubMed ID: 7985007
    [No Abstract]   [Full Text] [Related]  

  • 12. Imanishi-Kari case. Baltimore defends paper at center of misconduct case.
    Stone R
    Science; 1995 Jul; 269(5221):157. PubMed ID: 7618074
    [No Abstract]   [Full Text] [Related]  

  • 13. Definitions and boundaries of research misconduct: perspectives from a federal government viewpoint.
    Price AR
    J Higher Educ; 1994; 65(3):286-97. PubMed ID: 11653365
    [No Abstract]   [Full Text] [Related]  

  • 14. NIH office plans research on misconduct.
    Dalton R
    Nature; 1999 Jul; 400(6740):99. PubMed ID: 10408427
    [No Abstract]   [Full Text] [Related]  

  • 15. "Thank God for the lawyers": some thoughts on the (mis)regulation of scientific misconduct.
    Reynolds GH
    Tenn Law Rev; 1999; 66(3):801-18. PubMed ID: 12625356
    [No Abstract]   [Full Text] [Related]  

  • 16. Imanishi-Kari ruling slams ORI.
    Kaiser J; Marshall E
    Science; 1996 Jun; 272(5270):1864-5. PubMed ID: 8658151
    [No Abstract]   [Full Text] [Related]  

  • 17. Scientific misconduct. Ill-defined, redefined.
    Palca J
    Hastings Cent Rep; 1996; 26(5):4. PubMed ID: 8891701
    [No Abstract]   [Full Text] [Related]  

  • 18. Science, integrity, and investigators' rights: current challenges.
    Daniell WE
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S152-62. PubMed ID: 8921570
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating the oversight of scientific misconduct.
    Redman BK; Merz JF
    Account Res; 2005; 12(3):157-62. PubMed ID: 16634167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Federal actions against plagiarism in research.
    Price AR
    J Infor Ethics; 1996; 5(1):34-51. PubMed ID: 11653389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.